Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1981 6
1982 3
1983 9
1984 6
1985 9
1986 11
1987 7
1988 10
1989 15
1990 27
1991 22
1992 27
1993 27
1994 48
1995 35
1996 51
1997 40
1998 60
1999 49
2000 61
2001 47
2002 45
2003 59
2004 37
2005 49
2006 52
2007 37
2008 44
2009 38
2010 42
2011 52
2012 47
2013 61
2014 53
2015 52
2016 53
2017 55
2018 56
2019 37
2020 42
2021 38
2022 28
2023 14
2024 11
2025 25
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,469 results

Results by year

Filters applied: . Clear all
Page 1
Calcitriol supplementation after kidney transplantation: results of a double-blinded, randomized, placebo-controlled trial.
Khairallah P, Cortez NE, McMahon DJ, Sammons S, Agarwal S, Crew RJ, Cohen DJ, Dube GK, Mohan S, Chang JH, Morris HK, Fernandez HE, Aponte MA, Adebayo AO, Aghi A, Zaninotto M, Plebani M, Tripepi G, Gallieni M, Cosma C, Fusaro M, Nickolas TL. Khairallah P, et al. J Bone Miner Res. 2025 May 24;40(5):603-616. doi: 10.1093/jbmr/zjaf044. J Bone Miner Res. 2025. PMID: 40089990 Free PMC article. Clinical Trial.
In this randomized placebo-controlled study of calcitriol administration in kidney transplant recipients on corticosteroid-sparing immunosuppression, calcitriol did not improve bone quality and strength but was associated with higher rates of hypercalcemia. ...Howev …
In this randomized placebo-controlled study of calcitriol administration in kidney transplant recipients on corticosteroid-sparing im …
Randomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients.
Leaf DE, Shenoy T, Zinchuk K, Gupta S, Dias JA, Sanchez-Almanzar D, Ginde AA, Athar H, Cheng C, Tamura T, Kim EY, Waikar SS. Leaf DE, et al. JCI Insight. 2025 Sep 9;10(20):e193523. doi: 10.1172/jci.insight.193523. eCollection 2025 Oct 22. JCI Insight. 2025. PMID: 40924491 Free PMC article. Clinical Trial.
We also performed RNA-Seq on circulating CD14+ monocytes collected immediately prior to randomization and 2 days later.RESULTSThe global rank score for the primary endpoint was similar among calcifediol- (n = 51) versus placebo- (n = 49) treated patients (P = 0.85) and for cal …
We also performed RNA-Seq on circulating CD14+ monocytes collected immediately prior to randomization and 2 days later.RESULTSThe global ran …
Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL, Goa KL. Dechant KL, et al. Drugs Aging. 1994 Oct;5(4):300-17. doi: 10.2165/00002512-199405040-00006. Drugs Aging. 1994. PMID: 7827399 Review.
Overall, calcitriol is well tolerated. As shown in clinical studies, at recommended dosages hypercalcaemia is infrequent and mild, generally responding to reductions in calcium intake and/or calcitriol dosage. ...Nonetheless, at this stage, calcitriol should …
Overall, calcitriol is well tolerated. As shown in clinical studies, at recommended dosages hypercalcaemia is infrequent and mild, ge …
Does Preoperative Calcium and Calcitriol Decrease Rates of Post-Thyroidectomy Hypocalcemia? A Randomized Clinical Trial.
Donahue C, Pantel HJ, Yarlagadda BB, Brams D. Donahue C, et al. J Am Coll Surg. 2021 Jun;232(6):848-854. doi: 10.1016/j.jamcollsurg.2021.01.016. Epub 2021 Feb 23. J Am Coll Surg. 2021. PMID: 33631337 Clinical Trial.
Postoperative supplementation with calcium and calcitriol reduces its occurrence; however, prophylactic preoperative supplementation has not been studied systematically. ...These findings do not support the practice of routine calcium and calcitriol supplementation …
Postoperative supplementation with calcium and calcitriol reduces its occurrence; however, prophylactic preoperative supplementation …
Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency: a randomized, single-blind, controlled clinical trial.
Wen Y, Li L, Deng Z. Wen Y, et al. BMC Infect Dis. 2022 May 5;22(1):436. doi: 10.1186/s12879-022-07427-x. BMC Infect Dis. 2022. PMID: 35513795 Free PMC article. Clinical Trial.
BACKGROUND: This study aimed to evaluate whether calcitriol supplementation enhances CD4(+) T cell count and prognosis in patients with tuberculosis and low 25(OH)D levels. ...The Low-Vit-D group was randomized to the Low-25(OH)D and Low-25(OH)D-Calcitriol groups. A …
BACKGROUND: This study aimed to evaluate whether calcitriol supplementation enhances CD4(+) T cell count and prognosis in patients wi …
Therapeutic efficacy of zoledronic acid combined with calcium and calcitriol in the treatment of senile osteoporosis in elderly patients.
Zhang Y, Tian Y, Chen X. Zhang Y, et al. Inflammopharmacology. 2025 Apr;33(4):1899-1905. doi: 10.1007/s10787-025-01683-4. Epub 2025 Mar 5. Inflammopharmacology. 2025. PMID: 40042722 Clinical Trial.
OBJECTIVE: To investigate the effectiveness and safety of combining zoledronic acid with calcium supplements and calcitriol in treating primary osteoporosis in elderly patients. METHODS: Seventy-eight elderly patients with primary osteoporosis were recruited. They were ran …
OBJECTIVE: To investigate the effectiveness and safety of combining zoledronic acid with calcium supplements and calcitriol in treati …
Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial.
Nugroho P, Lydia A, Soewondo P, Suhardjono, Timan IS, Harimurti K, Ali Z. Nugroho P, et al. Ann Med. 2025 Dec;57(1):2577271. doi: 10.1080/07853890.2025.2577271. Epub 2025 Oct 27. Ann Med. 2025. PMID: 41145267 Free PMC article. Clinical Trial.
Urinary nephrin levels decreased in the calcitriol group, while change in the placebo group varied. Although UACR decreased more in the calcitriol group, the difference was not statistically significant (p = 0.099). ...The strong correlation between changes in IL-6 …
Urinary nephrin levels decreased in the calcitriol group, while change in the placebo group varied. Although UACR decreased more in t …
The effect of calcitriol and cholecalciferol on inflammatory markers in periprocedural myocardial injury: A randomized controlled trial.
Mahmoudi L, Izadpanah P, Asadi S. Mahmoudi L, et al. Medicine (Baltimore). 2025 Apr 11;104(15):e42103. doi: 10.1097/MD.0000000000042103. Medicine (Baltimore). 2025. PMID: 40228253 Free PMC article. Clinical Trial.
Hence, our goal was to evaluate the impact of calcitriol and cholecalciferol as vitamin D receptors agonists on inflammatory biomarkers in patients who are undergoing elective PCI. ...Calcitriol and cholecalciferol were administered at doses of 1 mcg and 300,000 int …
Hence, our goal was to evaluate the impact of calcitriol and cholecalciferol as vitamin D receptors agonists on inflammatory biomarke …
Topical calcitriol--studies on local tolerance and systemic safety.
Rizova E, Corroller M. Rizova E, et al. Br J Dermatol. 2001 Apr;144 Suppl 58:3-10. doi: 10.1046/j.1365-2133.2001.144s58003.x. Br J Dermatol. 2001. PMID: 11501511 Review.
Calcitriol 3 microg g(-1) ointment (Silkis ointment, Galderma Laboratories) is a new treatment for psoriasis. ...Preclinical studies have shown an effect of topical calcitriol on calcium homeostasis at doses higher than those in clinical use. No adverse local events …
Calcitriol 3 microg g(-1) ointment (Silkis ointment, Galderma Laboratories) is a new treatment for psoriasis. ...Preclinical studies …
The efficacy and safety of topical rapamycin-calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind, randomized clinical trial.
Chen PL, Hong JB, Shen LJ, Chen YT, Wang SJ, Liao YH. Chen PL, et al. Br J Dermatol. 2020 Oct;183(4):655-663. doi: 10.1111/bjd.18949. Epub 2020 Mar 18. Br J Dermatol. 2020. PMID: 32064596 Clinical Trial.
In period 1, either topical rapamycin 0.1% or calcitriol 0.0003% single-agent therapy vs. their combination was applied in a double-blind, left-right-randomized, split-face comparison. ...RESULTS: The mean changes in mFASI at week 12 compared with baseline were -0.92, -0.4 …
In period 1, either topical rapamycin 0.1% or calcitriol 0.0003% single-agent therapy vs. their combination was applied in a double-b …
1,469 results